Corporate Governance

  • MIKE LOBINSKY
    CEO

    Mike Lobinsky brings over 20 years in Medical Device Development. Served as U.S. Vice President, Sales and Implementation – Robotics at Smith & Nephew, which he joined through their 2016 acquisition of Blue Belt Technologies, a global leader in surgical robotics. At Blue Belt, he served as Vice President, Sales, leading all sales related activities for the company’s Navio surgical system, which provides robotics-assistance in knee replacement surgery. From 2006 to 2013, Mr. Lobinsky served in roles of increasing responsibly at BioMedix Vascular Solution, most recently as Vice President, Sales and Marketing. He has also held sales, marketing and management positions at Stryker Imaging, BrainLAB and Dentsply.

    Mike has a Bachelor’s degree in Economics and Business Administration from University of Wisconsin – River Falls.

     

  • Gérard Hascoët
    Chairman of the Board

    Gérard Hascoët began his career in the medical technology business of Thomson CGR. As a serial entrepreneur, in 1985, he founded Technomed International, which is now a part of EDAP TMS, a Company dedicated to non-invasive medical treatment in urology. In 1993, he founded Sometec, a hemodynamic monitoring company acquired by Arrow International, and IMMI, a neurosurgical robotics company acquired by ISS. From 2008 to 2011, Gérard was CEO of SpineVision, a spinal implant company, and he continues to serve on the company’s Board of Directors. In 2009, he co-founded MD Start, a European incubator for medical technology companies, where he holds the position of Executive Chairman. Gérard is also a Venture Partner of Sofinnova, one of the leading European healthcare venture capital firms.

    Gérard holds a degree in engineering from E.C.E Paris.

  • Marie Meynadier
    Board Member

    Marie Meynadier has over 25 years of experience int the high tech and medical device Industries. After receiving her doctorate, she joined Bellcore (Red Bank, NJ) and ATT Bell Labs (Murray Hill, NJ), where she conducted research on semiconductor devices. She then returned to France to lead the management of major national and international development programs in electronics, optics and microelectronics, which enabled the creation of several start-ups in these areas. Marie joined the medical field in 1999, taking leadership at the start-up Biospace lab, where she specialized in preclinical imaging and rapidly turned it into a profitable business. She has been exclusively dedicated to EOS imaging since 2008.

    Marie holds a degree in Electronic Engineering from Sup Telecom and a PhD (Doctorate) from the Ecole Normale Supérieure.

  • Marie-Laure Garrigues
    Board Member

    Marie Laure Garrigues is the Director of Investments at Bpifrance. She started her career in Sanofi Diagnostics Pasteur, where she had various managerial responsibilities in R&D and marketing as the Direction of Operations. She next served as the Director of Microbiology in Bio-Rad laboratories, a California based company that develops diagnostic products.

    Marie-Laure Garrigues is trained as a pharmacist and a former intern in medical biology. She holds a master’s degree in Pharmacy in Paris V University.

  • Eric Beard
    Board Member

    Eric Beard joined Baxter Healthcare in 1975, where he pursued an international career, principally in North America, Asia Pacific and Europe. He held various positions of increasing responsibility in finance and later was in charge of Baxter's renal products in various countries and regions. In 1999, Eric assumed global responsibility for the dialysis business as President. In 2001, he was appointed President of Baxter EMEA. He joined Sorin Group in 2003 as International President in charge of worldwide sales and marketing. Eric is currently Chairman of Cellnovo.

    Eric holds a degree in engineering from E.C.E Paris.

  • Antoine Vidal
    Board Member

    Antoine Vidal has more than 10 years of experience in asset management and corporate finance, mostly in the healthcare and medical equipment industries.  Antoine has been an Executive Director in the health division of Fosun, in charge of European healthcare investments, since September 2017.  He has also been heading Fosun Management (France) since August 2018. Before joining Fosun, Antoine was a Partner at Valiance Advisors LLP, a London-based investment company providing growth capital to innovative medical device companies.  Between 2008 and 2013, Antoine held several positions in Mergers & Acquisitions and Capital Markets at Royal Bank of Scotland.